SHL Medical hat dies direkt geteilt
🚀Since its launch, SHL Medical's Molly has supported approximately 20 combination products in multiple disease areas, such as diabetes, inflammatory diseases, and weight loss. Building on this success, Molly continues to evolve over the years. As cardiometabolic diseases become increasingly prevalent, the demand for innovative and reliable drug delivery solutions also grows. Featuring a modular platform technology with the advantages of scalable manufacturing, Molly is ideally suited to meet these challenges. Supported by SHL's vertically integrated capabilities, Molly is the go-to device for faster time-to-market demands. And better yet, Molly offers a wide range of customization options! 📱 Colors, 🔶shapes, and 🪟 viewing windows can all be tailored to meet patients' needs and pharma's branding purposes. We believe Molly is a device that you can fully trust to meet your requirements effectively. Read on for more details on Molly's achievements and our other successes: https://shorturl.at/FESAu #CardiometabolicCare #DrugDelivery #WeightLoss